Showing results (1991-2000 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|January 1, 1984
Intravenous immune globulin therapy for antibody immunodeficiencyF Savéry
Clinical Therapeutics|June 21, 2015
Extemporaneous Formulations of Metformin for Pediatric Endocrinology: Physicochemical Integrity, Cytotoxicity of Sweeteners, and Quantitation of Plasma LevelsRadamés Alemón-Medina, Juan Luis Chávez-Pacheco, Liliana Rivera-Espinosa, et al.
Clinical Therapeutics|June 22, 2015
Simultaneous Determination of Plasma Deferasirox and Deferasirox-Iron Complex Using an HPLC-UV System and Pharmacokinetics of Deferasirox in Patients With β-Thalassemia Major: Once-daily Versus Twice-daily AdministrationMeng-Yao Lu, Ning Wang, Wen-Hsin Wu, et al.
Clinical Therapeutics|June 24, 2015
Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy AdultsPeter E Haroldsen, Donald G Musson, Boyd Hanson, et al.
Clinical Therapeutics|January 1, 1981
Evaluation of short-term treatment with 30 mg of quazepam in insomniac outpatientsD E O'Hair, H J Winsauer
Clinical Therapeutics|January 1, 1981
Effects of benzothiazepine derivative (CRD-401) on blood pressure, excretion of electrolytes, and plasma renin activityT Funyu, K Nigawara, K Ohno, et al.
Clinical Therapeutics|January 1, 1984
Acute hemodynamic effects of acebutolol and propranololA Nigri, E Mangieri, E Martuscelli, et al.
Clinical Therapeutics|August 24, 2021
Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) StudyLisa Chu, Mark Fuller, Kathyrn Jervis, et al.
Clinical Therapeutics|August 12, 2021
Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United StatesCynthia Z Qi, Vamsi Bollu, Hongbo Yang, et al.
Clinical Therapeutics|May 28, 2020
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652, a Reversible Fatty Acid Amide Hydrolase Inhibitor, in Healthy, Nonelderly, Japanese Men and Elderly, Japanese Men and Women: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Phase I StudyMasaomi Takizawa, Toshifumi Hatta, Hiromi Iitsuka, et al.
Pageof 680